Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD
Stephen Moore, Eric Alsop, Ileana Lorenzini, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 1, pp. 49-65
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration
Frederick J. Arnold, Alexandra F. Putka, Urmimala Raychaudhuri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5587-5587
Open Access | Times Cited: 16
RNA dysregulation in neurodegenerative diseases
Yini Li, Shuying Sun
The EMBO Journal (2025) Vol. 44, Iss. 3, pp. 613-638
Open Access | Times Cited: 3
Nucleocytoplasmic transport defects in neurodegeneration — Cause or consequence?
Saskia Hutten, Dorothee Dormann
Seminars in Cell and Developmental Biology (2019) Vol. 99, pp. 151-162
Closed Access | Times Cited: 76
Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons
Yingxiao Shi, Shu‐Ting Hung, Gabriel S. Rocha, et al.
JCI Insight (2019) Vol. 4, Iss. 15
Open Access | Times Cited: 56
The Editor’s I on Disease Development
Mamta Jain, Michael F. Jantsch, Konstantin Licht
Trends in Genetics (2019) Vol. 35, Iss. 12, pp. 903-913
Open Access | Times Cited: 55
Nucleo–cytoplasmic transport defects and protein aggregates in neurodegeneration
Giacomo Bitetto, Alessio Di Fonzo
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 53
Reduction of A-to-I RNA editing in the failing human heart regulates formation of circular RNAs
Karoline Elizabeth Kokot, Jasmin M. Kneuer, David John, et al.
Basic Research in Cardiology (2022) Vol. 117, Iss. 1
Open Access | Times Cited: 30
Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
Ileana Lorenzini, Eric Alsop, Jennifer Lévy, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer’s disease
Amanda L. Wright, Lyndsey M. Konen, Bruce G. Mockett, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 15
Cytosine-to-uracil RNA editing is upregulated by pro-inflammatory stimulation of myeloid cells
Hyomin Seo, Winston H. Cuddleston, Ting Fu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Dysregulation of AMPA receptor subunit expression in sporadic ALS post‐mortem brain
Jenna M. Gregory, Matthew R. Livesey, Karina McDade, et al.
The Journal of Pathology (2019) Vol. 250, Iss. 1, pp. 67-78
Open Access | Times Cited: 42
Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases
Takashi Hosaka, Takenari Yamashita, Akira Tamaoka, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3148-3148
Open Access | Times Cited: 41
Role and therapeutic potential of liquid–liquid phase separation in amyotrophic lateral sclerosis
Donya Pakravan, Gabriele Orlando, Valérie Bercier, et al.
Journal of Molecular Cell Biology (2020) Vol. 13, Iss. 1, pp. 15-28
Open Access | Times Cited: 33
RNA editing of microtubule-associated protein tau circular RNAs promotes their translation and tau tangle formation
Justin R. Welden, Giorgi Margvelani, Karol Andrea Arizaca Maquera, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 22, pp. 12979-12996
Open Access | Times Cited: 20
MATR3 pathogenic variants differentially impair its cryptic splicing repression function
Mashiat Khan, Xiao Xiao Chen, Michelle Dias, et al.
FEBS Letters (2024) Vol. 598, Iss. 4, pp. 415-436
Open Access | Times Cited: 4
ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations
Khadija Hajji, Jiří Sedmík, Anna Cherian, et al.
RNA (2022) Vol. 28, Iss. 10, pp. 1281-1297
Open Access | Times Cited: 17
The Hitchhiker’s Guide to Nucleocytoplasmic Trafficking in Neurodegeneration
Stephen Moore, Benjamin E. Rabichow, Rita Sattler
Neurochemical Research (2020) Vol. 45, Iss. 6, pp. 1306-1327
Closed Access | Times Cited: 27
Aging through an epitranscriptomic lens
Mary McMahon, Craig M. Forester, Rochelle Buffenstein
Nature Aging (2021) Vol. 1, Iss. 4, pp. 335-346
Closed Access | Times Cited: 22
Riluzole does not ameliorate disease caused by cytoplasmic TDP‐43 in a mouse model of amyotrophic lateral sclerosis
Amanda L. Wright, Paul A. Della Gatta, Sheng Le, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 6, pp. 6237-6255
Open Access | Times Cited: 21
A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations
Korina Karagianni, Spyros Pettas, Georgia Christoforidou, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 465-465
Open Access | Times Cited: 14
Roles of Aging, Circular RNAs, and RNA Editing in the Pathogenesis of Amyotrophic Lateral Sclerosis: Potential Biomarkers and Therapeutic Targets
Takashi Hosaka, Hiroshi Tsuji, Shin Kwak
Cells (2023) Vol. 12, Iss. 10, pp. 1443-1443
Open Access | Times Cited: 8
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Xiaoqiang Tang, Arturo Toro, T. G. Sahana, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 23
RNA Editing and Modifications in Mood Disorders
Alessandro Barbon, Chiara Magri
Genes (2020) Vol. 11, Iss. 8, pp. 872-872
Open Access | Times Cited: 22
Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells
Georgie Lines, Jackie M. Casey, Elisavet Preza, et al.
Molecular and Cellular Neuroscience (2020) Vol. 109, pp. 103553-103553
Open Access | Times Cited: 22
RNA Editing in Neurological and Neurodegenerative Disorders
Pedro Henrique Costa Cruz, Yukio Kawahara
Methods in molecular biology (2020), pp. 309-330
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top